1. US Food and Drug Administration . Pfizer-BioNTech COVID-19 Vaccine (BNT162, PF-07302048). Vaccines and Related Biological Products Advisory Committee Briefing Document. Washington, DC: US Food & Drug Administration; 2020. Available at: https://www.fda.gov/media/144246/download
2. US Food and Drug Administration . MRNA-1273 Sponsor Briefing Document. Vaccines and Related Biological Products Advisory Committee Briefing Document. Washington, DC: US Food & Drug Administration; 2020. Available at: https://www.fda.gov/media/144434/download
3. US Food and Drug Administration . Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19. Vaccines and Related Biological Products Advisory Committee Briefing Document. Washington, DC: US Food & Drug Administration; 2021. Available at: https://www.fda.gov/media/146217/download
4. Hillson K, Clemens SC, Madhi SA, et al.. Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination. Lancet. 2021;398(10312):1683–1684. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530465/
6. Orvieto R, Noach-Hirsh M, Segev-Zahav A, et al.. Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle? Reprod Biol Endocrinol. 2021;19(1):69. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116639/
7. Bentov Y, Beharier O, Moav-Zafrir A, et al.. Ovarian follicular function is not altered by SARS-CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination. Hum Reprod. 2021;36(9):2506–2513. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385874/
1. US Food and Drug Administration . Pfizer-BioNTech COVID-19 Vaccine (BNT162, PF-07302048). Vaccines and Related Biological Products Advisory Committee Briefing Document. Washington, DC: US Food & Drug Administration; 2020. Available at: https://www.fda.gov/media/144246/download
2. US Food and Drug Administration . MRNA-1273 Sponsor Briefing Document. Vaccines and Related Biological Products Advisory Committee Briefing Document. Washington, DC: US Food & Drug Administration; 2020. Available at: https://www.fda.gov/media/144434/download
3. US Food and Drug Administration . Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19. Vaccines and Related Biological Products Advisory Committee Briefing Document. Washington, DC: US Food & Drug Administration; 2021. Available at: https://www.fda.gov/media/146217/download
4. Hillson K, Clemens SC, Madhi SA, et al.. Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination. Lancet. 2021;398(10312):1683–1684. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530465/
6. Orvieto R, Noach-Hirsh M, Segev-Zahav A, et al.. Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle? Reprod Biol Endocrinol. 2021;19(1):69. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116639/
7. Bentov Y, Beharier O, Moav-Zafrir A, et al.. Ovarian follicular function is not altered by SARS-CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination. Hum Reprod. 2021;36(9):2506–2513. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385874/